Journal of Biological Engineering

Journal of Biological Engineering is a peer-reviewed open access journal covering all aspects of biological engineering, published by BioMed Central since 2007 as the official journal of the Institute of Biological Engineering, with a 2025 Journal Impact Factor of 6.3《生物工程杂志》（Journal of Biological Engineering）是一份国际同行评审开放获取期刊，创刊于 2007 年，由生物医学中心（BioMed Central）出版，为生物工程研究所（Institute of Biological Engineering）官方期刊，涵盖生物工程各领域，2025 年影响因子为 6.3。

Scope

• Biological engineering is presented as an emerging discipline encompassing engineering theory and practice applied to biological science, just as mechanical engineering is rooted in physics and chemical engineering in chemistry生物工程被界定为一门新兴学科，涵盖应用于生物科学的工程理论与实践，正如机械工程扎根于物理学、化学工程扎根于化学。
• The journal welcomes submissions on the continuum of genetics, cells, molecules and systems, enabling the convergence of biology and engineering across varied life science applications本刊欢迎涵盖遗传学、细胞、分子与系统连续谱的投稿，推动生物学与工程学在各类生命科学应用中交汇。
• Topical areas include synthetic biology and cellular design, biomolecular, cellular and tissue engineering, bioproduction and metabolic engineering, and biosensors重点领域包括合成生物学与细胞设计、生物分子与细胞及组织工程、生物制造与代谢工程以及生物传感器。
• Further topical areas are ecological and environmental engineering, and biological engineering education and the biodesign process其它重点领域包括生态与环境工程，以及生物工程教育与生物设计流程。
• The journal also provides a home for research on biological information science, product formation, wastes and remediation本刊同时关注生物信息科学、产品形成、废弃物与修复方面的研究。
• All submissions, including reviews, must demonstrate significant novelty and discuss the broader context connecting the work to other areas of the field所有投稿（含综述）均须具备实质性创新，并讨论工作与领域内其它方向的广泛联系。
• Article types include research articles, methodology articles, reviews, letters to the editor, editorials and meeting reports文章类型包括研究论文、方法学论文、综述、读者来信、社论与会议报告。

History

• The journal was launched on 10 October 2007 by BioMed Central as the official journal of the Institute of Biological Engineering, and the first six papers appeared on that date该刊于 2007 年 10 月 10 日由生物医学中心（BioMed Central）创刊，成为生物工程研究所（Institute of Biological Engineering）官方期刊，首批六篇论文于同日发表。
• It grew out of the refereed proceedings of the IBE annual meetings, and a 2006 special issue of Biotechnology Progress paved the way for the new journal该刊源自生物工程研究所年会的同行评审会议论文，2006 年《生物技术进展》（Biotechnology Progress）学会专辑为新刊奠定基础。
• Mark R. Riley of the University of Arizona was the founding editor-in-chief, followed by Mark A. Eiteman of the University of Georgia in 2009亚利桑那大学（University of Arizona）的 Mark R. Riley 为首任主编，佐治亚大学（University of Georgia）的 Mark A. Eiteman 于 2009 年接任。
• BioMed Central was acquired by Springer Science+Business Media in October 2008 and became part of Springer Nature after the 2015 merger, and the journal moved to the Editorial Manager submission system in 2015生物医学中心（BioMed Central）于 2008 年 10 月被施普林格科学与商业媒体（Springer Science+Business Media）收购，2015 年合并后并入施普林格自然（Springer Nature），该刊同年改用 Editorial Manager 投稿系统。
• Jeong-Yeol Yoon and Raj R. Rao have served as editors-in-chief since 2013 and 2016 respectively, supported by regional editors for Asia/Pacific and Europe and a board of associate editorsJeong-Yeol Yoon 与 Raj R. Rao 分别自 2013 年与 2016 年起任共同主编，编委会另设亚太与欧洲区域编辑及多位副编辑。
• The journal received its first official impact factor of 2.481 for 2014, and the Journal Impact Factor reached 6.5 in 2024 and 6.3 in 2025该刊 2014 年获得首个官方影响因子 2.481，影响因子 2024 年为 6.5，2025 年为 6.3。

Editors

• The editors-in-chief are Jeong-Yeol Yoon, professor of biomedical engineering at the University of Arizona, and Raj R. Rao, professor of biomedical engineering at the University of Arkansas现任共同主编为亚利桑那大学（University of Arizona）生物医学工程教授 Jeong-Yeol Yoon 与阿肯色大学（University of Arkansas）生物医学工程教授 Raj R. Rao。
• Yoon directs the Biosensors Lab at Arizona, works on smartphone and paper microfluidic biosensors, and served as president of the Institute of Biological EngineeringYoon 主持亚利桑那大学生物传感器实验室（Biosensors Lab），研究智能手机与纸基微流控生物传感器，曾任生物工程研究所（Institute of Biological Engineering）主席。
• Rao, a fellow of AIMBE and BMES, studies cellular engineering and stem cell fate for regenerative therapies and served as department head at Arkansas from 2016 to 2022Rao 为美国医学与生物工程研究院（AIMBE）与生物医学工程学会（BMES）会士，研究细胞工程与再生医学中的干细胞命运，2016 至 2022 年任阿肯色大学生物医学工程系主任。
• The founding editor-in-chief Mark Riley and past editor-in-chief Mark Eiteman remain listed on the board, alongside two regional editors and about twenty associate editors创刊主编 Mark Riley 与前任主编 Mark Eiteman 仍列名编委会，编委会另设两位区域编辑及约二十位副编辑。
• The editorial board and associate editors are drawn from the United States, the United Kingdom, Germany, China, South Korea, India, Mexico and other countries编委会与副编辑来自美国、英国、德国、中国、韩国、印度与墨西哥等国。
• Review is single anonymized, typically with two or more reviewers per manuscript, and authors must submit a cover letter explaining fit with the journal, competing interests and originality评审采用单盲方式，每篇稿件通常由至少两位审稿人评审，作者须提交投稿信说明稿件契合度、利益冲突与原创性。
• The journal is fully open access, charges an article processing charge of 2,290 pounds, 3,090 dollars or 2,590 euros, and archives content in PubMed Central, CLOCKSS and Portico该刊为完全开放获取期刊，收取 2290 英镑、3090 美元或 2590 欧元的文章处理费，内容存档于 PubMed Central、CLOCKSS 与 Portico。